ANNA VASS: Open Payments
NPI 1609313824 · ADA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 25 payments from 14 companies in 2025. Trend: 2023 $113 · 2024 $252 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 4 | $76 |
| Insulet Corporation | 1 | $75 |
| Xeris Pharmaceuticals, Inc. | 3 | $60 |
| Sequel Med Tech, LLC | 3 | $58 |
| Lilly USA, LLC | 3 | $50 |
| Mannkind Corporation | 2 | $42 |
| Madrigal Pharmaceuticals | 1 | $37 |
| Novo Nordisk Inc | 2 | $37 |
| Corcept Therapeutics | 1 | $25 |
| Antares Pharma, Inc. | 1 | $24 |
Products named: iLet Bionic Pancreas, Omnipod, GVOKE HYPOPEN, TWIIST, MOUNJARO, AFREZZA, REZDIFFRA, Saxenda.
Industry payments across OK — which companies pay providers there.
